Table of Content
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing R&D Activities by Major Market Players
4.2.2 Growing Focus Towards Cloning & Transgenic Animals
4.3 Market Restraints
4.3.1 Ethical Issues Associated with Animal Biotechnology Products
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Diagnostic Tests
5.1.2 Reproductive & Genetic Products
5.1.3 Vaccines
5.1.4 Drugs
5.2 By Application
5.2.1 Development of Animal Pharmaceuticals
5.2.2 Food Safety and Drug Development
5.2.3 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bayer AG
6.1.2 Biogenesis Bago
6.1.3 Boehringer Ingelheim GmbH
6.1.4 Ivaoes, LLC
6.1.5 Merck & Co.,Inc.
6.1.6 Pfizer Inc.
6.1.7 Santa Cruz Biotechnology, Inc.
6.1.8 Virbac
6.1.9 Zoetis Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS